Browsing: AstraZeneca News
Several major corporations have decided to rejoin the CBI as the lobby group makes strides in rebuilding its credibility and governance structures.Firms such as AstraZeneca, Unilever,…
Recently, significant corporations such as AstraZeneca and Unilever have decided to rejoin the Confederation of British Industry (CBI). This decision follows CBI’s restructuring efforts post-misconduct allegations.The…
Biopharmaceutical company AstraZeneca has finalised its acquisition of Canadian cancer specialist Fusion Pharmaceuticals Inc for a total of $2.4bn (£1.88bn). Fusion Pharmaceuticals is a clinical-stage biopharmaceutical…
Astrazeneca has agreed to acquire Amolyt Pharma, a clinical-stage biotech with a focus on rare endocrine diseases, for up to $1.05bn (£819m). This acquisition will enhance…
AstraZeneca CEO David Brennan announces early retirement as first quarter profit falls 38%
Anglo-Swedish pharmaceutical company AstraZeneca plc (LSE:AZN) (STO:AZN) (NYSE:AZN) announced today that its chief executive, David Brennan, has decided to retire and step down from the board…
Amadeus House 27b Floral Street London WC2E 9DP United Kingdom
editor@financial-news.co.uk.
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.